Cargando…

Inhaled glucocorticoid-induced metabolome changes in asthma

OBJECTIVE: The aim of this study was toidentify dose-related systemic effects of inhaled glucocorticoids (GCs) on the global metabolome. DESIGN AND METHODS: Metabolomics/lipidomic analysis from plasma was obtained from 54 subjects receiving weekly escalating doses (µg/day) of fluticasone furoate (FF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daley-Yates, Peter, Keppler, Brian, Brealey, Noushin, Shabbir, Shaila, Singh, Dave, Barnes, Neil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346266/ https://www.ncbi.nlm.nih.gov/pubmed/35900313 http://dx.doi.org/10.1530/EJE-21-0912

Ejemplares similares

Therapeutic index of inhaled corticosteroids in asthma: A dose–response comparison on airway hyperresponsiveness and adrenal axis suppression
por: Daley‐Yates, Peter, et al.
Publicado: (2020)

Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial
por: Daley-Yates, Peter, et al.
Publicado: (2022)

Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management
por: Daley-Yates, Peter, et al.
Publicado: (2023)

New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management
por: Singh, Dave, et al.
Publicado: (2022)

Correction to: Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management
por: Daley-Yates, Peter, et al.
Publicado: (2023)

Correction to: New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management
por: Singh, Dave, et al.
Publicado: (2022)

Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA(®) Dry Powder Inhaler
por: Prime, David, et al.
Publicado: (2015)

Pharmacology Versus Convenience: A Benefit/Risk Analysis of Regular Maintenance Versus Infrequent or As-Needed Inhaled Corticosteroid Use in Mild Asthma
por: Daley-Yates, Peter, et al.
Publicado: (2021)

Inhaled corticosteroids: potency, dose equivalence and therapeutic index
por: Daley-Yates, Peter T
Publicado: (2015)

Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
por: Kachroo, Priyadarshini, et al.
Publicado: (2021)

Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study
por: Bremner, Peter R., et al.
Publicado: (2018)

Effect of High Dose Inhaled Glucocorticoids on Quality of Life in Patients with Moderate to Severe Asthma
por: Choi, Jae-Sung, et al.
Publicado: (2005)

The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma
por: Singh, Dave, et al.
Publicado: (2010)

Preventing clinically important deterioration with single-inhaler triple therapy in COPD
por: Naya, Ian, et al.
Publicado: (2018)

Glucocorticoid-Induced Cardiomyopathy Caused by Uncontrollable Asthma
por: Uehara, Hiroki, et al.
Publicado: (2023)

Serum interleukin-5 levels are elevated in mild and moderate persistent asthma irrespective of regular inhaled glucocorticoid therapy
por: Joseph, Jose, et al.
Publicado: (2004)

Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium/Vilanterol via a Single Inhaler in Patients with COPD
por: Mehta, Rashmi, et al.
Publicado: (2018)

Single inhaler triple therapy (SITT) in asthma: Systematic review and practice implications
por: Agusti, Alvar, et al.
Publicado: (2021)

The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen induced responses in mild asthma
por: Leaker, Brian R, et al.
Publicado: (2014)

Inhalation of Iodine in Asthma
por: Westmoreland, J. G.
Publicado: (1877)

The use of inhaled corticosteroids in pediatric asthma: update
por: Hossny, Elham, et al.
Publicado: (2016)

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
por: Halpin, David M.G., et al.
Publicado: (2018)

Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects
por: Bordag, Natalie, et al.
Publicado: (2015)

Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER
por: Singh, Dave, et al.
Publicado: (2020)

Guidance is needed on inhaled glucocorticoids and acute adrenal crises
por: Mackenzie, Scott D
Publicado: (2012)

Is inhaled glucocorticoids the only culprit in angina bullosa hemorrhagica?
por: Yorulmaz, Ahu, et al.
Publicado: (2018)

DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach
por: Singh, Dave, et al.
Publicado: (2023)

Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review
por: Kankaanranta, Hannu, et al.
Publicado: (2004)

Network analysis of quantitative proteomics on asthmatic bronchi: effects of inhaled glucocorticoid treatment
por: O'Neil, Serena E, et al.
Publicado: (2011)

Correction to: DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach
por: Singh, Dave, et al.
Publicado: (2023)

On Inhaling the Smoke of Datura in Asthma
por: Christie, Thomas
Publicado: (1811)

Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

Inhaled corticosteroids: not just for asthma, but for COVID-19?
por: Liew, Felicity, et al.
Publicado: (2022)

Effects of inhaled carbon monoxide and glucocorticoids in porcine endotoxin sepsis
por: Koulouras, V, et al.
Publicado: (2008)

Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
por: Facchinetti, Fabrizio, et al.
Publicado: (2021)

Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD
por: Price, David, et al.
Publicado: (2011)

Comparison of the effect of beclometasone/formoterol in asthma patients after methacholine‐induced bronchoconstriction: A noninferiority study using metered dose vs. dry powder inhaler
por: Singh, Dave, et al.
Publicado: (2019)

Asthma progression and mortality: the role of inhaled corticosteroids
por: O'Byrne, Paul, et al.
Publicado: (2019)

Inhaled Corticosteroids
por: Barnes, Peter J.
Publicado: (2010)

A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices
por: van der Palen, Job, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ggdmaigv5f4mgid4v3rr4dpvti